HCPCS Level II code S9991 designates services provided as part of a Phase III clinical trial. This code captures clinical care and associated trial-related services delivered during late-stage investigational studies, which are critical for evaluating safety and efficacy before potential regulatory approval. Nationally, accurate use of this code supports appropriate tracking of clinical trial services, billing transparency, and payer coverage decisions.

Key payers referenced in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of how S9991 is used in billing for Phase III research care, summaries of payer coverage patterns, and the clinical context that defines the service line and sites of care. The publication also highlights benchmarks and policy developments relevant to billing and reimbursement for trial-related services, and clarifies where input data is unavailable.

This executive summary provides a national perspective intended for providers, billing professionals, and policy analysts seeking clarity on coding for Phase III clinical-trial services and the implications for payer interactions and institutional billing practices.